Welcome to the Penn Center for AIDS Research (CFAR)
The Penn Center for AIDS Research (Penn CFAR) is one of 20 NIH-funded CFARs and includes HIV and AIDS investigators at the University of Pennsylvania, the Children's Hospital of Philadelphia (CHOP), and the Wistar Institute.
The Penn CFAR's mission is to support, encourage and facilitate research in all areas of HIV/AIDS on the Penn/CHOP/Wistar campus by (a) facilitating communication and interdisciplinary collaborations through workshops, working groups, strategic planning efforts, and a seminar series covering all topics in the field; (b) support innovative pilot research in HIV/AIDS through developmental pilot grant programs including nonhuman primate-based research; (c) mentoring and support of junior investigators; (d) services and training in support of HIV research through Shared Cores: Clinical, Viral/Molecular, Immunology, Biostatistics & Data Management; Behavioral and Social Sciences; International; Nonhuman Primate.
In the News
- A team led by A.T. Charlie Johnson (Professor of Physics in the School of Arts & Sciences), David Issadore (Assistant Professor in the School of Engineering and Applied Science), and Ronald Collman (Professor of Medicine in the Perelman School of Medicine) were awarded a Gates Grand Challenge Grant to a develop novel point-of-care HIV diagnosis and monitoring assay based on nanotechnology, microfluidics, and graphed-based sensor technology. Read more here...
George M. Shaw, MD, PhD, a professor of Hematology/Oncology and Microbiology in the Perelman School of Medicine at the University of Pennsylvania, has received $16.3 million over five years from the National Institute of Allergy and Infectious Diseases (NIAID) to develop a long-sought-after HIV vaccine. Read more here...
Three-year Study Will Help Researchers Design a Program That Promotes HIV Awareness and Prevention Options Among Women: Dr. Anne Teitelman of Penn School of Nursing and Dr. Beryl Koblin of the New York Blood Center, in partnership with local community consulting groups, have received a 3-year grant from the National Institute of Mental Health to embark on designing and evaluating an awareness, uptake and adherence support program for Pre-Exposure Prophylaxis (PrEP) among women in Philadelphia and New York City. Read more here.
Dental Medicine’s Kelly Jordan-Sciutto, Cagla Akay Espinoza and grad student Patrick Gannon led work that reveals how certain HIV treatments cause neuronal damage. Read more here.
A new study led by CFAR investigators Katherine Bar, MD, and Pablo Tebas, MD, with colleagues at the NIH and other institutions, reveal the impact of passive immunization with broadly neutralizing antibodies on HIV rebound and virus selection after treatment interruption and was published in the New England Journal of Medicine. Read more here.
José Bauermeister, PhD, MPH, Presidential Associate Professor of Nursing in the Department of Family and Community Health, leads a research team that has just been awarded a $9 million grant from the National Institutes of Health (NIH). The team, comprised of Penn Nursing, the University of Michigan School of Nursing, and Emory University’s Rollins School of Public Health, will adapt and test an HIV prevention intervention for adolescent men who have sex with men. The intervention, referred to as iCON (“I Connect”), builds on an Herb Ritts Foundation initiative and seeks to address the growing disparity in new HIV cases among young men by offering life skills training and community-based HIV prevention resources through an online app.Read more...